Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide

EU orphan designation number: EU/3/07/478   
Active ingredient: N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide
Indication: Treatment of Hodgkin lymphoma
Sponsor: CanReg (Europe) Limited
Templetown, Carlingford, County Louth, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Centralised Orphan - Designation EMEA/OD/053/07 (2007)4328 of 14/09/2007
06/11/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/053/07/T/01 (2008)6721 of 04/11/2008
27/03/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/053/07/T/02 (2009)2320 of 25/03/2009